2009Xumu shouyi xuebaoRequires access

Pharmacokinetics/Pharmacodynamics Integration of Florfenicol against E.coli in Pigs ex vivo

Zeng ZhenLing

Open publisher page 0 citations

Abstract

For the rational usage of florfenicol to treat the colibacillosis of pigs,the integration of pharmacokinetics in vivo and pharmacodynamics in vitro was used to study the antibacterial activity of florfenicol against E.coli in pig serum ex vivo.The accurate MIC of florfenicol against E.coli in MH broth and serum was 3.25 and 8.75 μg·mL-1,respectively.Florfenicol was absorbed slowly and anomaly in pigs after intramuscular administration(20 mg·kg-1).The Cmax was(5.28±1.48) μg·mL-1 at(3.60±1.52) h.The elimination of florfenicol was slow in pigs.Mean residence time(MRT) was(26.61±9.81) h.Elimination half-life(t1/2β) was(17.49±8.04) h.EC50 was(7.76±4.53) h.AUC0→24/MIC was(7.69±1.48) h and Cmax/MIC was(0.60±0.17).Because of the poor activity of florfenicol against E.coli and the lower plasma Cmax of florfenicol in pigs,it may fail to get desirable treatment result when curing the infection of E.coli in pigs by the routine regimen.

About this research paper

What this paper is about

For the rational usage of florfenicol to treat the colibacillosis of pigs,the integration of pharmacokinetics in vivo and pharmacodynamics in vitro was used to study the antibacterial activity of florfenicol against E.coli in pig serum ex vivo.The accurate MIC of florfenicol against E.coli in MH broth and serum was 3.25 and 8.75 μg·mL-1,respectively.Florfenicol was absorbed slowly and anomaly in pigs after intramuscular administration(20 mg·kg-1).The Cmax was(5.28±1.48) μg·mL-1 at(3.60±1.52) h.The elimination of florfenicol was slow in pigs.Mean residence time(MRT) was(26.61±9.81) h.Elimination half-life(t1/2β) was(17.49±8.04) h.EC50 was(7.76±4.53) h.AUC0→24/MIC was(7.69±1.48) h and Cmax/MIC was(0.60±0.17).Because of the poor activity of florfenicol against E.coli and the lower plasma Cmax of florfenicol in pigs,it may fail to get desirable treatment result when curing the infection of E.coli in pigs by the routine regimen.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

For the rational usage of florfenicol to treat the colibacillosis of pigs,the integration of pharmacokinetics in vivo and pharmacodynamics in vitro was used to study the antibacterial activity of florfenicol against E.coli in pig serum ex vivo.The accurate MIC of florfenicol against E.coli in MH broth and serum was 3.25 and 8.75 μg·mL-1,respectively.Florfenicol was absorbed slowly and anomaly in pigs after intramuscular administration(20 mg·kg-1).The Cmax was(5.28±1.48) μg·mL-1 at(3.60±1.52) h.The elimination of florfenicol was slow in pigs.Mean residence time(MRT) was(26.61±9.81) h.Elimination half-life(t1/2β) was(17.49±8.04) h.EC50 was(7.76±4.53) h.AUC0→24/MIC was(7.69±1.48) h and Cmax/MIC was(0.60±0.17).Because of the poor activity of florfenicol against E.coli and the lower plasma Cmax of florfenicol in pigs,it may fail to get desirable treatment result when curing the infection of E.coli in pigs by the routine regimen.

Key concepts: Florfenicol, Cmax, Pharmacokinetics, Pharmacology, Pharmacodynamics, In vivo, Biology, Ex vivo

Related papers

Back to paper searchBrowse research topicsOriginal source
Pharmacokinetics/Pharmacodynamics Integration of Florfenicol against E.coli in Pigs ex vivo — Research Paper | ScholarLens